Beta Drugs
BETANSE

Beta Drugs

₹1,330.1024.80 (1.90%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,300.10
Today’s high
1,367.60
52 week low
990.10
52 week high
2,000.00
Open price
1,316.80
Previous close
1,305.30
Live volume
9,348
Lower circuit
1,064.10
Upper circuit
1,596.10

Fundamentals

Market Cap
₹1,348Cr
ROE
18.96%
P/E Ratio(TTM)
32.51
EPS(TTM)
40.91
P/B Ratio
5.91
Dividend Yield
0.00%
Industry P/E
33.38
Book Value
224.93
Debt to Equity
0.66
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹89.58
-15.79%
Profit (Cr)
₹8.52
-30.28%
031.2562.593.75125
Dec '24
Sep '25
Dec '25
Revenue growthValue
3Y CAGR+26%
Profit growthValue
3Y CAGR+20%

About

Beta Drugs Limited manufactures pharmaceutical formulations, specializing in oncology products and potent drugs.;
CEO/MD
Mr. Rahul Batra
Founded in
2005
NSE symbol
BETA

Shareholding Pattern

Jun '25
Sep '25
Nov '25
Dec '25
Mar '26
Promoters
66.73%
Retail And Others
32.07%
Foreign Institutions
0.90%
Other Domestic Institutions
0.29%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹752.05
+23.65 (3.25%)
L
    H
    4,298.1632.464.21
    ₹363.58
    -12.06 (3.21%)
    L
      H
      3,963.6182.8614.99
      ₹403.70
      -6.40 (1.56%)
      L
        H
        3,788.6942.275.19
        Aarti DrugsAARTIDRUGS
        ₹376.30
        +2.95 (0.79%)
        L
          H
          3,423.0816.912.33
          Livesquawk
          Beta Drugs achieves regulatory milestones in Azerbaijan and the Philippines. The company is now aiming for GMP approval in the near term.
          Livesquawk
          Beta Drugs to acquire 66.09% stake in Nivian Life Sciences for ₹694M.
          2025
          6
          Nov
          Result
          Release date

          26
          Mar
          Bonus
          Ex date
          20:1
          Ratio

          For every 20 shares you hold, you will receive 1 additional shares
          Bonus ratio1:20
          Ex date26 Mar ‘25
          Record date26 Mar ‘25
          Announcement date21 Mar ‘25

          21
          Mar
          Bonus
          Announced
          20:1
          Ratio

          For every 20 shares you hold, you will receive 1 additional shares
          Bonus ratio1:20
          Ex date26 Mar ‘25
          Record date26 Mar ‘25
          Announcement date21 Mar ‘25
          Events calendar
          View upcoming events in other stocks